Population Health Sciences

You are here

Publications

Found 311 results

Author Title Type [ Year

]

Filters: First Letter Of Last Name is M [Clear All Filters]

2019

Slotwiner DJ, Raitt MH, Munoz FDel-Carpio, Mulpuru SK, Nasser N, Peterson PN. 2019. Impact of physiologic pacing versus right ventricular pacing among patients with left ventricular ejection fraction greater than 35%: A systematic review for the 2018 ACC/AHA/HRS guideline on the evaluation and management of patients.... Heart Rhythm. 16(9):e280-e298.

Baber JT, Mao J, Sedrakyan A, Connolly PH, Meltzer AJ. 2019. Impact of provider characteristics on use of endovenous ablation procedures in Medicare beneficiaries.. J Vasc Surg Venous Lymphat Disord. 7(2):203-209.e1.

Baber JT, Mao J, Sedrakyan A, Connolly PH, Meltzer AJ. 2019. Impact of provider characteristics on use of endovenous ablation procedures in Medicare beneficiaries.. J Vasc Surg Venous Lymphat Disord. 7(2):203-209.e1.

Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JC. 2019. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.. Int J Radiat Oncol Biol Phys.

D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al.. 2019. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.

D'Onofrio G, E Edelman J, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, Martel SH, VanVeldhuisen P, Oden N, Murphy SM et al.. 2019. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).. Implement Sci. 14(1):48.

McCrimmon T, Gilbert L, Hunt T, Terlikbayeva A, Wu E, Darisheva M, Primbetova S, Kuskulov A, Davis A, Dasgupta A et al.. 2019. Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial.. Implement Sci. 14(1):62.

McCrimmon T, Gilbert L, Hunt T, Terlikbayeva A, Wu E, Darisheva M, Primbetova S, Kuskulov A, Davis A, Dasgupta A et al.. 2019. Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial.. Implement Sci. 14(1):62.

Salemi A, Sedrakyan A, Mao J, Elmously A, Wijeysundera H, Tam DY, Di Franco A, Redwood S, Girardi LN, Fremes SE et al.. 2019. Individual Operator Experience and Outcomes in Transcatheter Aortic Valve Replacement.. JACC Cardiovasc Interv. 12(1):90-97.

Kasabwala K, Patel N, Cricco-Lizza E, Shimpi AA, Weng S, Buchmann RM, Motanagh S, Wu Y, Banerjee S, Khani F et al.. 2019. The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy.. Eur Urol Oncol. 2(2):135-140.

Kasabwala K, Patel N, Cricco-Lizza E, Shimpi AA, Weng S, Buchmann RM, Motanagh S, Wu Y, Banerjee S, Khani F et al.. 2019. The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy.. Eur Urol Oncol. 2(2):135-140.

Veinot TC, Ancker JS, Cole-Lewis H, Mynatt ED, Parker AG, Siek KA, Mamykina L. 2019. Leveling Up: On the Potential of Upstream Health Informatics Interventions to Enhance Health Equity.. Med Care. 57 Suppl 6 Suppl 2:S108-S114.

Veinot TC, Ancker JS, Cole-Lewis H, Mynatt ED, Parker AG, Siek KA, Mamykina L. 2019. Leveling Up: On the Potential of Upstream Health Informatics Interventions to Enhance Health Equity.. Med Care. 57 Suppl 6 Suppl 2:S108-S114.

Ding T, Song T, Zhou B, Geber A, Ma Y, Zhang L, Volk M, Kapadia SN, Jenkins SG, Salvatore M et al.. 2019. Microbial Composition of the Human Nasopharynx Varies According to Influenza Virus Type and Vaccination Status.. MBio. 10(4)

Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al.. 2019. No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.

Vina ER, Hannon MJ, Masood H, Hausmann LRM, Ibrahim SA, Dagnino J, Arellano A, C Kwoh K. 2019. Non-steroidal Anti-inflammatory Drug Use in Chronic Arthritis Pain: Variations by Ethnicity.. Am J Med.

Aviki EM, Schleicher SM, Mullangi S. 2019. The Oncology Care Model and Other Value-Based Payment Models in Cancer Care.. JAMA Oncol. 5(3):298-299.

Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP. 2019. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.. Drug Alcohol Depend. 200:34-39.

Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al.. 2019. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.

Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al.. 2019. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.

Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al.. 2019. Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.

Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP. 2019. A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.. Leuk Lymphoma. :1-5.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Lazow SP, Venn RA, Lubor B, Kocharian G, Kreines FM, Gilbert E, Marnell CS, Cricco-Lizza E, Cooley V, Christos P et al.. 2019. The PreOp Program: Intensive Preclinical Surgical Exposure is Associated With Increased Medical Student Surgical Interest and Competency.. J Surg Educ.